CHOICE HOTELS INTERNATIONAL INC /DE (CHH) earnings date, results and what the price requires
NYSE · SEC CIK 0001046311 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $440.8M | $64.3M | $1.41 | Filing |
| Mar 31, 2026 | Apr 30, 2026 | $340.6M | $20.3M | $0.44 | Filing |
| Dec 31, 2025 | Feb 19, 2026 | $390.1M | $63.6M | $1.35 | Filing |
| Sep 30, 2025 | Nov 5, 2025 | $447.3M | $180.0M | $3.86 | Filing |
| Jun 30, 2025 | Aug 6, 2025 | $426.4M | $81.7M | $1.75 | Filing |
| Mar 31, 2025 | May 8, 2025 | $332.9M | $44.5M | $0.94 | Filing |
| Dec 31, 2024 | Feb 20, 2025 | $389.8M | $75.8M | $1.56 | Filing |
| Sep 30, 2024 | Nov 4, 2024 | $428.0M | $105.7M | $2.22 | Filing |
What would CHOICE HOTELS INTERNATIONAL INC /DE have to report for its valuation to change?
At $106.92, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 5.3% a year, to $9.14. On that path the next quarter needs diluted EPS near $4.06, against $3.86 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 5.3% | 5.3% |
| EPS needed in final year | $9.14 | $9.14 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. CHH goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.